AAD 2023: Dupilumab Tied to Significant Improvements in Atopic Hand and Foot Dermatitis
Clinically meaningful reduction of itch seen as early as one week, with significant number of patients achieving clear/almost clear skin at 16 weeks
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.